PCSCR6N Stock Latest News
Private CompaniesScripta Therapeutics Highlights AI-Driven Platform Targeting Transcription Factors1M agoSCR6N
Private CompaniesScripta Therapeutics Highlights Seed Funding Milestone and Techbio Platform Progress2M agoSCR6N
Private CompaniesEarly-Stage ESG Integration Signals Strategic Focus at Scripta Therapeutics4M agoSCR6N
Private CompaniesAI-Driven Drug Discovery Strategy Highlights Scripta Therapeutics’ R&D Positioning4M agoSCR6N
Private CompaniesScripta Therapeutics – Weekly Recap5M agoSCR6N
Private CompaniesScripta Therapeutics Highlighted Among Oxford Deeptech Firms Seen as Ready for Series A5M agoSCR6NPrivate CompaniesScripta Therapeutics Highlighted as Oxford Deeptech Firm Poised for Series A5M agoSCR6N
Private CompaniesScripta Therapeutics Gains Venture Spotlight for Data-Driven AI Drug Discovery Model6M agoSCR6N
Private CompaniesScripta Therapeutics Highlighted for Data-Driven AI Drug Discovery Approach6M agoSCR6N
Private CompaniesScripta Therapeutics Highlighted for Data-Driven Target Discovery Approach6M agoSCR6N
Private CompaniesMMC Ventures Report Highlights Scripta Therapeutics’ Data-Driven Drug Discovery Model6M agoSCR6N
Private CompaniesMMC Ventures Report Spotlights Scripta Therapeutics’ Data-Driven Drug Discovery Model6M agoSCR6N
Private CompaniesScripta Therapeutics Highlights Transcription Factor Strategy in Alzheimer’s R&D6M agoSCR6N



